A & G Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
A & G Pharmaceuticals, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include EQUIZONE 100. The owner is based in Clarksburg, NJ.
P.O.Box 365
Clarksburg, NJ 08510
Showing of trademarks Trademarks
Trademark Classifications
A & G Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does A & G Pharmaceuticals, Inc. have?
A & G Pharmaceuticals, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 3 abandoned.
What trademark classes does A & G Pharmaceuticals, Inc. file in?
A & G Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are A & G Pharmaceuticals, Inc.'s most well-known trademarks?
A & G Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as EQUIZONE 100. These are among 1 currently registered trademark in the portfolio.
What is A & G Pharmaceuticals, Inc.'s trademark registration success rate?
A & G Pharmaceuticals, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.